A new blood test pioneered by diagnostics company AOA Dx (AOA) can detect ovarian cancer in symptomatic women with high accuracy, a study by researchers from the Universities of Manchester and ...

A prospective study found that a multicancer blood test detected signals across 17 cancer types with 99.64% specificity, but ...

New clinical research has identified a blood test that can reveal which women are more likely to respond to a particular treatment for ovarian cancer, known as PARP inhibitor therapy. The work appears ...

Add Yahoo as a preferred source to see more of our stories on Google. Ovarian cancer is usually diagnosed using a mix of scans and blood tests (Getty/iStock) A straightforward blood test shows promise ...

Experts say a nationwide study is now putting a new blood test to work in hopes of being able to catch ovarian cancer ...

There's no reliable screening test for ovarian cancer yet. A blood test in a nationwide study could change that, and high-risk women can join from home.

More than 300,000 women are diagnosed with ovarian cancer globally each year. The four-year clinical trial across 15 Australian hospitals – known as SOLACE2 – was co-led by the University of Sydney ...

There's no reliable screening test for ovarian cancer, but a blood test in a nationwide study could change that, and ...

Aug 15 (Reuters) - An experimental blood test detects early-stage ovarian cancer in patients with vague symptoms that would likely be misdiagnosed using currently available methods, researchers said ...

The FDA is expected to approve a new kind of blood test that may allow earlier diagnosis and less invasive, more effective ...

Ovarian cancer can be a difficult-to-detect disease early on because its symptoms often are vague and easily mistaken. Here ...

Australian scientists have created a blood test to guide more effective ovarian cancer treatment, by identifying the women more likely to respond to an ovarian cancer treatment known as PARP inhibitor ...